Showing results (1-10 of 39) with videos related to
Sort By:
Pageof 4
Clinical Calcium|February 29, 2012
[Evidence for osteoporosis treatment using PTH (1-34) daily subcutaneous injection]Takanori Yamamoto, Etsuro Hamaya, Hideaki SowaClinical Calcium|December 29, 2010
[Teriparatide: human recombinant parathyroid hormone (1-34) as a daily subcutaneous injection]Hideaki Sowa, Etsuro Hamaya, Takanori YamamotoClinical Interventions in Aging|July 18, 2015
Safety of daily teriparatide treatment: a post hoc analysis of a Phase III study to investigate the possible association of teriparatide treatment with calcium homeostasis in patients with serum procollagen type I N-terminal propeptide elevationTakanori Yamamoto, Mika Tsujimoto, Hideaki SowaCurrent Medical Research and Opinion|October 10, 2014
Quality of life in Japanese women with postmenopausal osteoporosis treated with raloxifene and vitamin D: post hoc analysis of a postmarketing studyHiroaki Ohta, Etsuro Hamaya, Masanori Taketsuna, et al.Menopause (New York, N.Y.)|March 11, 2015
Safety of 3-year raloxifene treatment in Japanese postmenopausal women aged 75 years or older with osteoporosis: a postmarketing surveillance studyYasuhiro Takeuchi, Etsuro Hamaya, Masanori Taketsuna, et al.Journal of Bone and Mineral Metabolism|November 9, 2012
Assessing the effect of baseline status of serum bone turnover markers and vitamin D levels on efficacy of teriparatide 20 μg/day administered subcutaneously in Japanese patients with osteoporosisTakanori Yamamoto, Mika Tsujimoto, Etsuro Hamaya, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 5, 2002
Smad3 promotes alkaline phosphatase activity and mineralization of osteoblastic MC3T3-E1 cellsHideaki Sowa, Hiroshi Kaji, Toru Yamaguchi, et al.Journal of Bone and Mineral Metabolism|December 26, 2013
The safety and effectiveness profile of daily teriparatide in a prospective observational study in Japanese patients with osteoporosis at high risk for fracture: interim reportTakanori Yamamoto, Masanori Taketsuna, Xiaoyan Guo, et al.The Journal of Biological Chemistry|July 20, 2002
Activations of ERK1/2 and JNK by transforming growth factor beta negatively regulate Smad3-induced alkaline phosphatase activity and mineralization in mouse osteoblastic cellsHideaki Sowa, Hiroshi Kaji, Toru Yamaguchi, et al.Pageof 4